liver institute of virginia education, research and treatment for patients with liver disease iver...

22
Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell L Shiffman, MD Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, VA, USA

Upload: morgan-hancock

Post on 17-Dec-2015

216 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

Liver Institute of VirginiaEducation, Research and Treatment for Patients with Liver Disease

IVerBon SecoursHealth System

WHY CHOOSE TELAPREVIR

Mitchell L Shiffman, MDLiver Institute of Virginia

Bon Secours Health SystemRichmond and Newport News, VA, USA

Page 2: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRTREATMENT NAÏVE AND RELAPSE

HCV RNA UD UD UD

RVRTelaprevir

PEGINF

Ribavirin

PEGINF

Ribavirin

No

RVRPEGINF-RBV

Log HCV < 3 < 3 UD

Stop Rule >3 >3 +

Week 4 8 12 16 20 24 28 32 36 40 44 48

ML Shiffman, R EstabanLiver Intl 2012; 32 (suppl 1):54-60.

Page 3: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRNON-RESPONSE AND CIRRHOSIS

RVR

HCV RNA

Telaprevir

PEGINF

RibavirinNo

RVRPEGINF-RBV

Log HCV < 3 < 3 UD

Stop Rule >3 >3 +

Week 4 8 12 16 20 24 28 32 36 40 44 48

ML Shiffman, R EstabanLiver Intl 2012; 32 (suppl 1):54-60.

Page 4: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

SVR RATESVERY COMPARABLE

Boceprevir Telaprevir

Treatment Naïve:

eRVR

Delayed response

% with eRVR

96%

66-75%

56%

89-92%

64%

58-60%

Retreatment:

Relapse

Partial response

Null response

INF sensitive (lead-in)

INF insensitive (lead-in)

69-75%

40-52%

NA

73-79%

33-34%

84-88%

56-61%

31-33%

NA

NA

Page 5: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

SVR RATESVERY COMPARABLE

Boceprevir Telaprevir

Treatment Naïve:

eRVR

Delayed response

% with eRVR

96%

66-75%

56%

89-92%

64%

58-60%

Retreatment:

Relapse

Partial response

Null response

INF sensitive (lead-in)

INF insensitive (lead-in)

69-75%

40-52%

NA

73-79%

33-34%

84-88%

56-61%

31-33%

NA

NA

Page 6: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

SVR RATESVERY COMPARABLE

Boceprevir Telaprevir

Treatment Naïve:

eRVR

Delayed response

% with eRVR

96%

66-75%

56%

89-92%

64%

58-60%

Retreatment:

Relapse

Partial response

Null response

INF sensitive (lead-in)

INF insensitive (lead-in)

69-75%

40-52%

NA

73-79%

33-34%

84-88%

56-61%

31-33%

NA

NA

Page 7: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRWHY CHOOSE THIS REGIMEN?

It is just an easier treatment regimen

Page 8: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRITS JUST EASIER

• All three medications are started at the same time• All patients get 12 weeks of telaprevir

• Treatment naïve• Prior relapse• Prior non-response• Cirrhosis

Page 9: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRITS JUST EASIER

• If you have to stop telaprevir at week 8 for adverse events the SVR is only marginally reduced.

50% 54%

TelaprevirPEGIFN-2a

RibavirinIf NO eRVR:

PEGINF + Ribavirin

If eRVR:PEGINF + Ribavirin

TelaprevirPEGIFN-2a

Ribavirin

128

83% 89%

Week of TPV

12 4824Weeks0 8

IM Jacobson et al.N Engl J Med 2011; 364:2405-16.

Page 10: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRITS JUST EASIER

• Only 2 treatment durations• Treatment naïve and prior relapsers:

• 24 weeks if achieve extended rapid response• 48 weeks with delayed response

• Prior non-response and cirrhosis• 48 weeks

Page 11: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRITS JUST EASIER

• 60% achieve eRVR. Treated for 24 weeks

• 21% have delayed response. Treated 48 weeks.

• 81% of patients become HCV RNA undetectable during treatment

0

20

40

60

80

100

% H

CV

RN

A (

-)

Page 12: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRITS JUST EASIER

• Smaller pill burden• 2 capsules TID = 6/day• Randomized controlled trial

suggests telaprevir can be dosed 3 capsules BID without impacting SVR

=

P Marcellin et al.Gastroenterol 2011; 140:459-468.

Page 13: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRITS JUST EASIER

0

1

2

3

4

5

6

7

-4 0 4 8 12 16

WEEKS

HC

V R

NA

(IU

/ml)

• Stop rules at weeks 4 and 12.

• Allows resistant virus to be recognized earlier.

• Resistance monitoring uses the same cutt-off.

• Week 4 >Log 3

• Week 12 >Log

• Week 24 negative

Page 14: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRNEGATIVE FEATURES

• Side effects of therapy

• Side effects of peginterferon and ribavirin

• Side effects of telaprevir

• Anemia

• Rash

• GI symptoms

Page 15: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

RASHUNIQUE TO TELAPREVIR

• Appears in over half of patients treated with telaprevir• Typically appears during first 4 weeks of treatment• Worsens progressively during treatment• Most patients never reach stage 3-4• If severe, can stop telaprevir a few weeks early• The decline in SVR is minimal even in patients with

delayed virologic response

Page 16: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRGRADE 2 RASH

Page 17: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRGRADE 3 RASH

Page 18: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRGRADE 4 RASH

Page 19: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRSIDE EFFCTS

• GI toxicity:• Nausea• Vomiting• Diarrhea• Anal-rectal burning

Page 20: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRSUMMARY

To treat HCV with Incevik

Is not a trick.

Just start it with PEG and Riba together.

Treat for 12 weeks and see it get better.

If negative at week 4.

Its virtually a cure.

Continue PEG and riba for sure.

Till week 24.

And then dash straight through the door.

Page 21: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRSUMMARY

However,

If the response is delayed.

Do not be dismayed.

For if less than a thousand by month 3.

A cure can still be.

Adhere to the stop rules at 4 and 12 weeks.

This is important and so do not cheat.

And you will see.

This rule will keep you mutant free.

Page 22: Liver Institute of Virginia Education, Research and Treatment for Patients with Liver Disease IVer Bon Secours Health System WHY CHOOSE TELAPREVIR Mitchell

IVer

TELAPREVIRSUMMARY

AEs include rash, anemia and a sore bum.

This is not fun.

This make patients glum.

And their physicians run.

And so my friends,When treating with telaprevir there is no reason to quiver.Because its dam good at getting HCVOut of the liver.